{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:40:44Z","timestamp":1740123644848,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10689-018-0098-y","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T03:23:19Z","timestamp":1534908199000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4028-8796","authenticated-orcid":false,"given":"Christina","family":"Edwinsdotter Ardnor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ros\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Ljuslinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Melin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,22]]},"reference":[{"issue":"1","key":"98_CR1","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265\u2013271","journal-title":"Am J Hum Genet"},{"issue":"11","key":"98_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Antoniou AC, Easton DF, Embrace (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822. \n                    https:\/\/doi.org\/10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"98_CR3","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Andrulis I (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313(13):1347\u20131361. \n                    https:\/\/doi.org\/10.1001\/jama.2014.5985","journal-title":"JAMA"},{"issue":"3","key":"98_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/gcc.20189","volume":"43","author":"BC Hendrickson","year":"2005","unstructured":"Hendrickson BC, Judkins T, Ward BD, Eliason K, Deffenbaugh AE, Burbidge LA, Pyne K, Leclair B, Ward BE, Scholl T (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast\/ovarian cancer families. Genes Chromosomes Cancer 43(3):309\u2013313. \n                    https:\/\/doi.org\/10.1002\/gcc.20189","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"98_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavicius","year":"2010","unstructured":"Janavicius R (2010) Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397\u2013412. \n                    https:\/\/doi.org\/10.1007\/s13167-010-0037-y","journal-title":"EPMA J"},{"key":"98_CR6","doi-asserted-by":"crossref","unstructured":"The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group (2000). Am J Hum Genet 67 (1):207\u2013212","DOI":"10.1086\/302974"},{"issue":"2","key":"98_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10689-015-9785-0","volume":"14","author":"PA James","year":"2015","unstructured":"James PA, Sawyer S, Boyle S, Young MA, Kovalenko S, Doherty R, McKinley J, Alsop K, Beshay V, Harris M, Fox S, Lindeman GJ, Mitchell G (2015) Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. Fam Cancer 14(2):287\u2013295. \n                    https:\/\/doi.org\/10.1007\/s10689-015-9785-0","journal-title":"Fam Cancer"},{"issue":"2","key":"98_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/cncr.29041","volume":"121","author":"J Mersch","year":"2015","unstructured":"Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK (2015) Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121(2):269\u2013275. \n                    https:\/\/doi.org\/10.1002\/cncr.29041","journal-title":"Cancer"},{"key":"98_CR9","doi-asserted-by":"publisher","unstructured":"Bratt O, Drevin L, Akre O, Garmo H, Stattin P (2016) Family history and probability of prostate cancer, differentiated by risk category: a nationwide population-based study. J Natl Cancer Inst 108 (10). \n                    https:\/\/doi.org\/10.1093\/jnci\/djw110","DOI":"10.1093\/jnci\/djw110"},{"issue":"5","key":"98_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/cge.12497","volume":"87","author":"V Sopik","year":"2015","unstructured":"Sopik V, Phelan C, Cybulski C, Narod SA (2015) BRCA1 and BRCA2 mutations and the risk for colorectal cancer. Clin Genet 87(5):411\u2013418. \n                    https:\/\/doi.org\/10.1111\/cge.12497","journal-title":"Clin Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-018-0098-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-018-0098-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:59:46Z","timestamp":1567231186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-018-0098-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,22]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1007\/s10689-018-0098-y","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2018,8,22]]},"assertion":[{"value":"22 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}